A 19-year-old Aboriginal woman from a remote Northern Territory community has a history of definite acute rheumatic fever at age 14 and moderate rheumatic mitral regurgitation. She has had irregular follow-up and last received prophylactic penicillin more than a year ago. She has no penicillin allergy. What is the most appropriate long-term secondary prophylaxis?